文献速递炎症性肠病

炎症性肠病与终末期肾病风险增加相关:基于人群的队列研究

Inflammatory Bowel Disease Is Associated With an Increased Risk of End-Stage Renal Disease: A Population-Based Cohort Study.
PubMed 文献 · Aliment Pharmacol Ther · 2026-07-14

该回顾性人群队列研究利用1984至2023年加拿大马尼托巴大学IBD流行病学数据库链接 administrative 医疗数据,纳入12,639例IBD患者与126,180例对照,评估终末期肾病(ESRD)及肾移植发生率并识别预测因素。结果显示IBD患者透析与肾移植发生率显著高于对照,IBD为ESRD独立预测因素(HR=1.53),克罗恩病风险高于溃疡性结肠炎,口服激素、别嘌醇及肠道手术为IBD人群透析启动的显著预测因素。

要点

  • IBD患者ESRD风险较一般人群增加约50%,克罗恩病风险高于溃疡性结肠炎。
  • 传统危险因素(糖尿病、高血压、充血性心力衰竭)仍为ESRD强预测因素。
  • IBD人群中口服激素、别嘌醇使用及肠道手术显著预测透析启动。

核心结论

  • IBD患者ESRD风险增加近50%,克罗恩病风险高于溃疡性结肠炎。
  • 肠道手术、别嘌醇使用及口服激素治疗是IBD人群透析启动的重要预测因素,强调需对IBD患者进行仔细肾脏监测。

研究设计与样本

  • 回顾性人群队列研究,使用马尼托巴大学IBD流行病学数据库链接1984至2023年行政医疗数据。
  • 纳入12,639例IBD患者,匹配126,180例对照。

主要发现

  • IBD患者透析发生率1.48% vs 对照0.82%(p<0.0001),肾移植发生率0.25% vs 0.10%(p<0.0001)。
  • IBD为ESRD独立预测因素(HR=1.53,95%CI 1.23-1.90),克罗恩病HR=1.93(95%CI 1.39-2.68),溃疡性结肠炎HR=1.28(95%CI 0.96-1.72)。
  • 传统危险因素:糖尿病HR=3.82(95%CI 3.22-4.53),高血压HR=1.91(95%CI 1.58-2.30),充血性心力衰竭HR=6.37(95%CI 5.25-7.72)。
  • IBD人群内,口服激素治疗OR=2.0(95%CI 1.06-3.81),别嘌醇使用OR=4.06(95%CI 1.49-11.1),肠道手术OR=2.77(95%CI 1.51-5.09)显著预测透析启动。

关键数值与推荐

  • ESRD定义为1年内需两次门诊透析索赔。
  • 预测因素采用比例风险回归和巢式病例对照逻辑回归分析识别。

临床怎么用

  • 对IBD患者应加强肾脏功能监测,尤其合并糖尿病、高血压、心力衰竭者。
  • 使用口服激素、别嘌醇或接受肠道手术的IBD患者需警惕透析启动风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Inflammatory bowel disease (IBD) is associated with renal complications, but population-based data on end-stage renal disease (ESRD) are limited. AIM: To evaluate the incidence of ESRD and renal transplantation in IBD compared with the general population and to identify predictive factors associated with ESRD in the IBD population. METHODS: This was a retrospective population-based cohort study using the University of Manitoba IBD Epidemiology Database linked to administrative healthcare data from 1984 to 2023 (12,639 IBD patients matched with 126,180 controls). ESRD was defined as requiring any two claims for outpatient dialysis within a 1-year period. Predictive factors were identified using proportional hazard regression and nested case-control logistic regression analyses. RESULTS: IBD patients had a significantly higher incidence of dialysis (1.48% vs. 0.82%, p < 0.0001) and kidney transplantation (0.25% vs. 0.10%, p < 0.0001) than controls. IBD was an independent predictor of ESRD (HR = 1.53, 95% CI 1.23-1.90), with stronger associations in CD (HR = 1.93, 95% CI 1.39-2.68) than UC (HR = 1.28, 95% CI 0.96-1.72). Traditional risk factors including diabetes (HR = 3.82, 95% CI 3.22-4.53), hypertension (HR = 1.91, 95% CI 1.58-2.30), and congestive heart failure (HR = 6.37, 95% CI 5.25-7.72) remained strongly predictive. Within the IBD population, oral steroid treatment (OR = 2.0, 95% CI 1.06-3.81), allopurinol use (OR = 4.06, 95% CI 1.49-11.1) and bowel surgery (OR = 2.77, 95% CI 1.51-5.09) significantly predicted dialysis initiation. CONCLUSIONS: Persons with IBD have an increased risk of ESRD by nearly 50%, with CD showing a greater risk than UC. Bowel surgery, allopurinol use and oral steroid therapy are important predictors, emphasising the necessity of careful renal monitoring in IBD patients.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Sattayalertyanyong O, Nugent Z, Barr B, et al. Inflammatory Bowel Disease Is Associated With an Increased Risk of End-Stage Renal Disease: A Population-Based Cohort Study. Aliment Pharmacol Ther. 2026. PMID: 42446205. doi:10.1111/apt.70845

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。